These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1084 related articles for article (PubMed ID: 17307281)

  • 21. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
    Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on high-density cultivation of Vero cells with biosilon solid microcarrier.
    Wang D; Xiao C; Chen Z; Huang Z
    Chin J Biotechnol; 1996; 12(2):119-29. PubMed ID: 8988358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an in situ detachment protocol of Vero cells grown on Cytodex1 microcarriers under animal component-free conditions in stirred bioreactor.
    Rourou S; Riahi N; Majoul S; Trabelsi K; Kallel H
    Appl Biochem Biotechnol; 2013 Aug; 170(7):1724-37. PubMed ID: 23737305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
    Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
    Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a serum-free medium for the growth of Vero cells and the production of reovirus.
    Butler M; Burgener A; Patrick M; Berry M; Moffatt D; Huzel N; Barnabé N; Coombs K
    Biotechnol Prog; 2000; 16(5):854-8. PubMed ID: 11027181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
    Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
    J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor.
    Trabelsi K; Majoul S; Rourou S; Kallel H
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
    Côté J; Garnier A; Massie B; Kamen A
    Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
    Kallel H; Jouini A; Majoul S; Rourou S
    J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple serum-free freezing medium for serum-free cultured cells.
    Merten OW; Petres S; Couvé E
    Biologicals; 1995 Jun; 23(2):185-9. PubMed ID: 7546662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspended aggregates as an immobilization mode for high-density perfusion culture of HEK 293 cells in a stirred tank bioreactor.
    Liu XM; Liu H; Wu BC; Li SC; Ye LL; Wang QW; Huang PT; Chen ZL
    Appl Microbiol Biotechnol; 2006 Oct; 72(6):1144-51. PubMed ID: 16568312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of rhEPO with a serum-free medium in the packed bed bioreactor.
    Deng J; Yang Q; Cheng X; Li L; Zhou J
    Chin J Biotechnol; 1997; 13(4):247-52. PubMed ID: 9631260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Goat serum: an alternative to fetal bovine serum in biomedical research.
    Paranjape S
    Indian J Exp Biol; 2004 Jan; 42(1):26-35. PubMed ID: 15274477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.